Breaking Barriers in Women’s Health: How the Definition of Women’s Health Impacts Clinical Trials and Future Generations

What Comes Next in Women’s Health? Exploring the Future

Lori Ellis, Head of Insights at BioSpace, hosted the second episode of their series on women’s health. The conversation delved into the potential impacts on clinical trial outcomes due to the current definition of women’s health. The guests included Sans Thakur, Founder and Chairwoman of Tower Capital; Chia Chia Sun, Chief Commercial Officer at Fab Biopharma; Elisa Cascade, Chief Product Officer at Advarra; Shawana Moore, Medical Advisor on the Advisory Council for Healthy Women; and Katie Schubert, President and Chief Executive Officer of the Society for Women’s Health.

The discussion explored how expanding the definition of women’s health can lead to increased funding to address women’s health issues. It also delved into how uncomfortable sharing complete medical histories can impact future generations if women hold the key to generational health. The episode is available on Spotify, Apple Podcasts, Amazon Music, and iHeart Radio.

Leave a Reply